金城医药：关于子公司通过高新技术企业重新认定的公告

Core Viewpoint - Jincheng Pharmaceutical's subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., has been re-certified as a high-tech enterprise, allowing it to continue paying a corporate income tax rate of 15% from 2025 to 2027 [1] Group 1 - The re-certification was conducted by the Guangdong Provincial Department of Science and Technology, the Guangdong Provincial Department of Finance, and the State Taxation Administration of Guangdong Province [1]